Drug Profile
Research programme: miRNA therapeutics - Pharmahungary
Alternative Names: miRNAtarget™ project - PharmahungaryLatest Information Update: 18 Jun 2021
Price :
$50
*
At a glance
- Originator Pharmahungary Group
- Class MicroRNAs
- Mechanism of Action MicroRNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Ischaemic heart disorders
Most Recent Events
- 01 Apr 2020 Pharmahungary and Horizon agree to co-develop microRNA for Ischaemic heart disorders
- 01 Apr 2020 Preclinical trials in Ischaemic heart disorders in Hungary (unspecified route), before April 2020
- 05 Jul 2016 Research programme; miRNA therapeutics - Pharmahungary is available for licensing -http://www.pharmahungary.com/in-house-r-d-projects